Adenoid Cystic Carcinoma

Also known as: Adenoid Cystic Carcinomas / ADCC / Adenoid cystic carcinoma (morphologic abnormality) / Carcinoma, Adenoid Cystic / Cylindroma / Cylindroma (morphologic abnormality) / Antibody-mediated lympholysis (function) / Antibody-dependent cellular cytotoxicity (function) / Antibody-Dependent Cell Cytotoxicity

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13982Lutetium Lu-1770Recruiting1
DB01590Everolimus1Completed1
DB00480Lenalidomide1Completed1
DB06192Nimotuzumab1Unknown Status1
DB12006Osugacestat1Recruiting1
DB04974Rimiducid1Active Not Recruiting1
DB14922Tislelizumab1Completed1
DB18052VMD-9281Recruiting1
DB12001Abemaciclib1 / 2Recruiting1
DB15279CB-1031 / 2Recruiting1
DB15279CB-1031 / 2Terminated1
DB00002Cetuximab1 / 2Unknown Status1
DB09078Lenvatinib1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB06626Axitinib2Completed1
DB00188Bortezomib2Completed1
DB00958Carboplatin2Recruiting1
DB00958Carboplatin2Withdrawn1
DB00002Cetuximab2Recruiting1
DB00515Cisplatin2Completed1
DB00380Dexrazoxane2Completed1
DB05928Dovitinib2Completed2
DB00997Doxorubicin2Completed1
DB16047Elraglusib2Recruiting1
DB16047Elraglusib2Withdrawn1
DB01590Everolimus2Completed1
DB00544Fluorouracil2Recruiting1
DB00619Imatinib2Unknown Status1
DB06186Ipilimumab2Active Not Recruiting1
DB00762Irinotecan2Recruiting1
DB09078Lenvatinib2Active Not Recruiting1
DB09078Lenvatinib2Recruiting1
DB00650Leucovorin2Recruiting1
DB13982Lutetium Lu-1772Completed1
DB13982Lutetium Lu-1772Not Yet Recruiting1
DB16778Lutetium Lu-177 vipivotide tetraxetan2Not Yet Recruiting1
DB00220Nelfinavir2Completed1
DB09035Nivolumab2Active Not Recruiting1
DB12006Osugacestat2Completed1
DB09037Pembrolizumab2Completed1
DB09037Pembrolizumab2Recruiting1
DB08896Regorafenib2Active Not Recruiting1
DB14765Rivoceranib2Completed1
DB14765Rivoceranib2Unknown Status2
DB01268Sunitinib2Completed1
DB00755Tretinoin2Completed1
DB06334Tucidinostat2Completed1
DB12737BrontictuzumabNot AvailableCompleted1